ArticleMolecular biology reports2025
Protective effect of abietic acid nanoparticles synthesized by gamma-irradiation against cisplatin-induced renal injury in mice: a promising novel natural nano-drug.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe goal of this study was to investigate the protective effects of abietic acid (AA) nanoparticles which were prepared using gamma-irradiation to ameliorate the nephrotoxicity induced by cisplatin (CP) in experimental mice.
methodForty eight mice were divided into eight groups (6 mice/group) as follows; control group I, group II (mice were received AA 40 mg/kg B.W.), group III (mice were received 40 mg/kg body weight AA nanoparticles), induction group IV (mice were injected with sole-dosage of CP), group V (mice were received 40 mg/kg body weight AA for 7 days, and at 7th day, they were injected with sole-dosage of CP), the other treated groups VI, VII, and VIII (mice were received 40, 20, and 10 mg/kg body weight AA nanoparticles respectively for one week and at 7th day, they were injected with single-dose of CP).
resultsOur findings exhibited that, with respect to the control group the CP induction group showed elevation in kidney functions (creatinine and urea). Additionally, the relative expression levels of nuclear factor kappa beta and caspase-3, as well as tissue levels of malondialdehyde, and interleukin-1β were significantly elevated, while tissue levels of total antioxidant capacity and glutathione were significantly decreased. The administration of AA or different doses of AA nanoparticles to mice prior to CP induction greatly attenuated the alterations that occurred in these parameters. In the induction group, the histological results revealed a unique pattern of kidney lesions, whereas the renal tissues in the treated groups before induction exhibited comparatively well-preserved construction. Pretreatment with AA nanoparticles (dose 40 mg/kg B.W) give the beast protective effect as indicated in almost biochemical parameters and histopathological investigation.
conclusionAs evidenced by the biochemical and histological alterations, AA nanoparticles reduce functions of the kidney and oxidative stress as an effective scavenger of free radicals to either avoid or diminish the harmful impacts of CP. It may also offer significant protection against CP-induced renal inflammation and apoptosis.
Indexed as
Identifiers
40748506What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.